Picture EBD Group BIO-Europe Spring 2019 BES Wien Vienna Austria 600x60px
Document › Details

Oryzon Genomics S.A.. (3/31/17). "Press Release: Oryzon Raises €18 Million through a Private Placement with US and European Investors [Not for US, CA, AU, JP, ZA, et al.]". Barcelona.

Organisations Organisation Oryzon Genomics S.A. (Madrid Stock Exchange: ORY)
  Group Oryzon Genomics (Group)
  Organisation 2 Guggenheim Securities, LLC
  Group Guggenheim (Group)
Products Product biopharmaceutical
  Product 2 investment banking
Index term Index term Oryzon Genomics–SEVERAL: investment, 201703 private placement €18.2m w 5.7m news common shares at €3.2/share
Person Person Buesa, Carlos (Oryzon Genomics SA 201404 CEO + Co-Founder)

Record changed: 2017-04-12


Picture EBD Group BIO-Europe Spring 2019 BES Wien Partnering Opens 600x60px

More documents for Oryzon Genomics (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Picture BIO Deutschland Biotech Investors Day BID 2019 Würzburg 600x60px

» top